MESOTHELIOMA RESEARCH
In the world are increasingly more cases of
Mesothelioma, which has led to more and more specialists are dedicated to
research on this disease.
So if you or someone in your family suffer from
this disease, I suggest you read this article until the end.
Because Mesothelioma is
such a rare disease, historically, not a lot of research dollars were spent to
learn new ways to diagnose and treat it. However, as the plight of asbestos
sufferers throughout the world has come to light in the past 20 years, more and
more doctors and scientists have begun to study the illness. Clinical trials
using conventional treatments, such as chemotherapy, are being conducted around
the world. Research into alternative treatments, such as immunotherapy,
virotherapy, and gene therapy, is also being carried out.
More and more research
centers dedicated specifically to the study of mesothelioma and other
asbestosrelated diseases are being opened in the United States and indeed
throughout the world. These centers become involved in cutting-edge studies
that are providing a better prognosis and longer lifespan for mesothelioma
victims. Hopefully, the same researchers developing these new testing methods
and treatments will eventually find a way to cure this aggressive cancer.
Becoming Part
of a Clinical Trial
If you are a mesothelioma
patient and would like to participate in mesothelioma research and clinical
trials, talk to your doctor about the ones for which you might qualify. There
are a number of different kinds of trials available to participants including:
• Treatment trials, which
test new cancer treatments, including drugs, radiation therapies,
chemotherapies, or multi-modal approaches to combating the disease.
• Prevention trials, which
test new methods of lowering the risk of developing a certain kind of cancer,
like mesothelioma.
• Screening trials, which
work to devise new ways to detect cancer. Tests like these that focus on
diagnosing cancer in its
early stages are especially pertinent to mesothelioma sufferers as the disease
is rarely diagnosed in Stage I or II.
• Supportive care trials,
which attempt to develop new palliative therapies to improve the quality of
life for someone suffering from this aggressive, debilitating cancer.
This was all
for today, please keep visiting us.
A hug and God Bless
JOHNY JARAMILLO
